The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000633:toxicity; D004285:Dogs; D004594:Electrophysiology; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008564:Membrane Potentials / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D010042:Ouabain; D010672:Phenytoin / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D004071:Digitalis Glycosides; D010042:Ouabain; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D011188:Potassium